Market & Industry

Bioactive peptides: From supplement to food

Bioactive peptides are moving from niche supplements into bars, drinks, and snacks. What this trend means for you and where regulation falls short

Published ·5 Sources ·independent & ad-free ·Methodology
Illustration: Bioactive peptides: From supplement to food
Symbolic image Illustration: Bioactive peptides: From supplement to food

Ireland: Bioactive peptides - short protein building blocks with specific biological functions - are moving from a niche supplement into mainstream products such as bars, drinks, and snacks. According to the manufacturer Glanbia Nutritionals, the peptide trend is reaching the broad food market, which means greater availability in supermarkets. However, scientific substantiation often lags behind commercial hype, and regulation is inconsistent, so the market development remains complex.

Bioactive peptides consist of short chains of amino acids and can have health-relevant effects such as lowering blood pressure or acting as antioxidants. They occur naturally in milk, plants, or fermented products and, according to market reports, are growing by 5.5 to 7.6 percent annually. These figures come mainly from fluctuating commercial reports and should therefore be viewed critically.

Bioactive Peptides: The Essentials at a Glance

  • According to Glanbia Nutritionals, bioactive peptides are reaching the mass market in bars, drinks, and snacks.
  • The market size for 2024 is estimated at 2.5 to 4.2 billion US dollars, which highlights the uncertain data situation.
  • In the EU, bioactive peptides are subject to the Novel Food Regulation, which entails lengthy approval procedures.
  • The dosage in fortified snacks is usually low, which is why they primarily serve to cover protein needs.
  • When buying, you should pay attention to the specific source and reputable studies, as many applications are still in the pilot phase.

What is driving the trend toward bioactive peptides in foods?

The main drivers are the rising demand for functional foods with added health value and the growing interest in protein and satiety, often amplified by the Ozempic effect. Manufacturers such as Glanbia Nutritionals use these protein building blocks to make products more attractive to health-conscious consumers. In markets like India, plant-based, vegan, and gluten-free formulations are gaining particular importance.

Market entry is made more difficult by complex regulatory hurdles such as the EU Novel Food Regulation and the currently unclear stance of the US FDA. The US market went through two years of regulatory turbulence; major suppliers closed, and a formal FDA update is still pending. For consumers, this means that genuine peptide products in the mass market are still rare and often high-priced, and manufacturers' advertising claims should always be questioned critically.

What role do bioactive peptides play in your diet?

Bioactive peptides in foods can usefully complement a protein-rich diet, but they do not achieve the potency of medicinal peptide hormones such as the GLP-1 agonists semaglutide or tirzepatide. Since the dosage in fortified snacks is usually very low, these products primarily serve as a building block for meeting protein needs and maintaining muscle. They do not replace a medically prescribed therapy.

When purchasing, you should pay attention to the specific source - milk, plant, or fermentation - and to the existence of reputable studies, since many applications are still in the pilot phase. You can find more information on the basics in the peptide library or in our glossary.

Market size: How is the bioactive peptide sector developing?

Estimates of the market size for bioactive peptides in 2024 vary widely: Market.us puts the value at 4.2 billion US dollars, while the forecast from Introspective Market Research is only 2.5 billion US dollars. This discrepancy highlights the uncertain data situation, even though a general growth trend is discernible that could lead to falling prices with fluctuating quality in the long term.

Within the market, functional foods and beverages dominate with a share of over 60 percent, with plant-based sources at 43 percent ahead of milk peptides at 34 percent. Powder forms are particularly widespread due to their ease of processing. These commercial market data should always be interpreted with caution because they originate from sales reports.

Regulation and safety: What is permitted for peptides in foods?

In the European Union, bioactive peptides are subject to the Novel Food Regulation (EU) 2015/2283, provided they do not have a traditional history of consumption, which entails lengthy and costly approval procedures. In contrast, the regulatory situation in the USA is characterized by a lack of a clear FDA stance. India divides functional foods via the FSSAI into eight specific categories such as nutraceuticals and novel foods.

As a consumer, you should check when purchasing whether a product has the necessary EU approval, which is usually evident from the ingredient list or packaging information. Keep in mind that peptides in foods serve as a supplement and cannot exert the medical effects of pharmaceuticals.

Learn more in our articles about fermented peptides as a snack trend as well as about the AI-supported discovery of bioactive peptides.

No medical advice: This article is for information only and does not replace medical or nutritional medical advice.

Not medical advice.

← Back to news

The Peptide Signal - monthly, ad-free Learn more